A safe and effective vaccine is a critical tool to control the COVID-19 pandemic. As of 25 June 2021, 23 vaccines had advanced to Stage 3 clinical trials1and more than a dozen had been approved in multiple countries2. The BNT162b vaccine from Pfizer–BioNTech, for example, has been app...
people_fully_vaccinated: total number of people who received all doses prescribed by the initial vaccination protocol. If a person receives the first dose of a 2-dose vaccine, this metric stays the same. If they receive the second dose, the metric goes up by 1. ...
Bombshell report from two eminent vaccine specialists reveals COVID mRNA vaccine cause auto immune system to attack vital organs after injection. Autopsies reveal auto immune attacks damages the deceaseds; heart, lings, liver, brain and blood vessels. 3 January 2022 3 January 2022 “On...
Step 1Preclinical TestA vaccine to animals such as mice or monkeys to see if it produces an immune response. Step 2 Phase I Safety Trials vaccine is given to a small number of people to test safety and dosage as well as to confirm that it stimulates the immune system Step 3 PHASE II ...
In a meta-analysis of national cohort studies on COVID-19 vaccination across the UK (England, Northern Ireland, Scotland, and Wales), undervaccination was associated with a higher risk of severe COVID-19 outcomes (ie. COVID-19 hospitalization or death) relative to full vaccination. The cohort...
As of May 2023, the country with the highest number of COVID deaths had over 1.1 million. There have been roughly 6.87 million deaths worldwide.
The approved COVID-19 vaccines have shown great promise in reducing disease transmission and severity of outcomes. However, the success of the COVID-19 vaccine rollout is dependent on public acceptance and willingness to be vaccinated. In this study, we
we observed regional differences in willingness to be vaccinated with greater hesitancy in participants in the South (Suppl. Table4). In the U.K., compared to participants in England, the age-adjusted ORs for vaccine hesitancy was 1.38 (1.25–1.51) for participants in Northern Ireland and 1.10...
Bhat et al., Journal of Infection, doi:10.1016/j.jinf.2023.03.004 Effect of calcifediol supplementation as add-on therapy on the immune repertoire in recipients of the ChAdOx1 nCoV-19 vaccine: A prospective open-label, placebo-controlled, clinical trial 34% fewer symptomatic cases (p=0.01). ...
Notably, most of the French and German regions as well as Finland, Iceland, Northern Ireland, southern Great Britain, Estonia, Latvia, and Hungary experienced comparatively lower losses. The spatial dynamics of excess mortality in Europe underwent a significant shift in the second pandemic year. In...